What You Should Know:
- Seqera, a provider of scientific data analysis for life sciences and creator of Nextflow, announced the acquisition of Tinybio, a rising tech-bio startup specializing in AI-powered bioinformatics tools.
- The acquisition reinforces Seqera's commitment to building a robust online platform that empowers scientists with cutting-edge resources. Financial details of the acquisition were not disclosed.
Bridging the Gap Between Scientists and
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
venBio Raises $528M for Fifth Life Sciences Fund
What You Should Know:
- venBio, a leading life sciences venture capital firm, announced the successful closing of its fifth fund, venBio Fund V, with over $528M in capital commitments.
- The new fund will focus on investing in biopharmaceutical companies developing innovative treatments for unmet medical needs.
venBio Fund V Focus
With a strong track record of successful investments in companies such as Labrys Biologics, Aragon Pharmaceuticals, and Seragon
Read More
Outpace Bio Secures $144M for AI-Powered Cell Therapy Platform
What You Should Know:
- Outpace Bio, a pioneering cell therapy company raises $144M in oversubscribed Series B financing round led by RA Capital Management with participation from both new and existing investors, including Qatar Investment Authority, Surveyor Capital, Sheatree Capital, Black Opal Ventures, Alexandria Venture Investments, and several others. Outpace has now raised a total of approximately $200M to date.
- Jake Simson, Partner at RA Capital Management, will join
Read More
Labcorp and Ultima Genomic Partner to Advance Whole Genome Sequencing for Cancer Research
What You Should Know:
- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with Ultima Genomics to utilize its UG 100TM sequencing solution and ppmSeqTM technology to explore new whole genome sequencing (WGS) clinical applications, including molecular residual disease (MRD) in patients with early-stage solid tumor cancers.
- Labcorp recently introduced Labcorp® Plasma Detect™, the first clinically validated,
Read More
OM1 Supporting Alzheimer’s Research and Care w/Expanded Dataset
What You Should Know:
- OM1, the leader in real-world insights synthesis and evidence generation for life sciences supporting population and personalized data insights, evidence generation through advanced validated AI platforms, big deep clinical data, registries, and globally recognized thought leadership today announced the new release of its Alzheimer’s disease PremiOM dataset.
- OM1 combines multiple real-world data sources – including specialists’ electronic medical records (EMR),
Read More
MISTR Offers Free STI Test Kits Available at Select Georgia Walmarts
What You Should Know:
- MISTR, a telemedicine provider for sexual health, is partnering with select Walmart locations in Georgia to offer free at-home STI test kits. This initiative aims to increase access to convenient and confidential testing, particularly in areas with high HIV transmission rates.
- MISTR goes beyond STI testing, offering telemedicine consultations for PrEP (pre-exposure prophylaxis) and long-term HIV care. Their focus on accessibility and education aims to
Read More
Transparency Launches to Tackle Counterfeit Prescription Crisis with Substance Test Kits
What You Should Know:
- Transparency, a harm reduction organization providing at-home drug testing kits for any substance, today announced its official launch and formation as the parent organization of the Bunk Police.
- Celebrated for its strong impact in the harm reduction space, the Bunk Police provides critical education and drug
Read More
Wexner Medical Center Launches Largest Precision Health Initiative in Ohio
What You Should Know:
- The Ohio State University Wexner Medical Center and Helix, the leading precision health organization in the nation, are launching the largest precision health initiative in Ohio, aimed at driving better health outcomes and more personalized care for all individuals in the state.
- The program, named Ohio State Genomic Health, will enroll 100,000 participants over four years and will provide important information about potential risks for health conditions by
Read More
PCR is the Gold Standard of Testing. How Can It Be Improved?
Most of us have been tested for COVID-19 over the past few years. If that’s true of you, you know the routine: you go to a testing site, give your sample, a medical professional sends it to a laboratory, and you receive your results in a day or two. If this sounds familiar, you’ve benefited from PCR (Polymerase Chain Reaction) testing.
PCR is well known for its accuracy. It has limitations, however: it’s costly, time-consuming, and requires samples to be sent to central laboratories.
Read More
Texas A&M Health and Burst IQ Partner to Optimize Clinical Genomics Research
What You Should Know:
-Texas A&M Health and BurstIQ, a leader in advanced data management, today announced a partnership to leverage LifeGraph®, a graph-powered, end-to-end data management platform, to transform clinical research.
-This collaboration aims to enhance patient and researcher interactions while ensuring the highest standards of patient privacy and data rights.
Texas A&M Health: Advancing Healthcare through Innovation and Research
Texas A&M Health is a
Read More
